HIGHLIGHTS
- who: Anja Schlu00f6r and colleagues from the Heinrich Heine University, Germany have published the paper: SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications, in the Journal: (JOURNAL)
- what: Frontiers in Immunology frontiersin.org 10.3389/fimmu.2022.930975 Conclusions: Collectively, the authors report novel camelid hcAbs suitable for diagnostics and potential therapy. The size of the library was with 1-3x107 PBMCs per donor animal (3 in total) very small but the five candidates chosen from the selection rounds in this study showed good binding properties . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.